CompletedPhase 3NCT00003280

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Studying Mantle cell lymphoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Swiss Cancer Institute
Principal Investigator: Michele Ghielmini, MD
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni
Intervention: rituximab(biological)
Enrollment: 240 target
Eligibility: 18-120 years · All sexes
Timeline: 1998 – 2002

Study locations (10)

Kantonspital Aarau, Aarau, Switzerland
Office of Walter Weber-Stadelman, Basel, Switzerland
University Hospital, Basel, Switzerland
Ospedale San Giovanni, Bellinzona, Switzerland
Inselspital, Bern, Bern, Switzerland
Hopital Cantonal Universitaire de Geneva, Geneva, Switzerland
Istituto Oncologico della Svizzera Italiana, Lugano, Switzerland
Burgerspital, Solothurn, Solothurn, Switzerland
City Hospital Triemli, Zurich, Switzerland
Klinik Hirslanden, Zurich, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00003280 on ClinicalTrials.gov

Other trials for Mantle cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Mantle cell lymphoma →

← Back to all trials